Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets

v3.8.0.1
Interim Consolidated Balance Sheets - USD ($)
Aug. 31, 2017
Nov. 30, 2016
CURRENT    
Cash and cash equivalent $ 254,894 $ 192,826
Accounts Receivable 27,542 32,534
Inventory 210,303 7,323
Prepaid expenses and other receivables 19,232 50,037
Total Current Assets 511,971 282,720
Deferred financing costs 0 36,874
Property and Equipment 29,813 50,496
TOTAL ASSETS 541,784 370,090
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 332,112 245,911
Promissory note payable 70,640 0
Unsecured Convertible Debentures, net of deferred financing costs of $nil and $35,769, respectively 76,125 1,117,771
Total Current Liabilities 478,877 1,363,682
Long term secured Convertible Debentures, net of deferred financing costs of $73,012 and $nil, respectively 1,821,807 0
Derivative Financial Liability 224,637 0
Total Liabilities 2,525,321 1,363,682
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2016 - nil). 0 0
Common stock, $0.001 par value 100,000,000 shares authorized (2016: 100,000,000), 56,732,099 issued and outstanding (2016: 55,104,493) 56,732 55,105
Additional Paid-In Capital 27,653,025 27,307,274
Deficiency (29,659,794) (28,298,613)
Accumulated other comprehensive loss (33,500) (57,358)
Total Stockholders' Deficiency (1,983,537) (993,592)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 541,784 $ 370,090